Anurag Chaudhary

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Molecular Dynamics Simulations

Structure Activity Relationship

Pulmonary Tuberculosis

Top Venues

Future medicinal chemistry

Current drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Alimuddin Saifi, Alok Sharma, Anurag Chaudhary, Nazia Siddiqui, Vrish Dhwaj Ashwlayan, Bhuwanendra Singh
Unveiling the Latest Breakthroughs: A Comprehensive Review of the Therapeutic Activity and Safety Profile of Aloe vera. Current drug safety (2024)
Alimuddin Saifi, Alok Sharma, Anurag Chaudhary, Nazia Siddiqui, Vrish Dhwaj Ashwlayan, Bhuwanendra Singh
Unveiling the Latest Breakthroughs: A Comprehensive Review of the Therapeutic Activity and Safety Profile of Aloe vera . Current drug safety 19 (4) (2024)
Neha Sharma, Anurag Chaudhary, Kamini Bhardwaj
An insight into the structure-activity relationship studies of anticancer medicinal attributes of 7-azaindole derivatives: a review. Future medicinal chemistry 15 (24) (2023)
Neha Sharma, Anurag Chaudhary, Kamini Bhardwaj
An insight into the structure-activity relationship studies of anticancer medicinal attributes of 7-azaindole derivatives: a review. Future medicinal chemistry 15 (24) (2023)
Neha Sharma, Anurag Chaudhary, Kamini Bhardwaj
An insight into the structure-activity relationship studies of anticancer medicinal attributes of 7-azaindole derivatives: a review. Future medicinal chemistry (2023)
Neha Sharma, Anurag Chaudhary, Kamini Bhardwaj
An insight into the structure-activity relationship studies of anticancer medicinal attributes of 7-azaindole derivatives: a review. Future medicinal chemistry 15 (24) (2023)
Mohd Imran, Mandeep Kumar Arora, Anurag Chaudhary, Shah Alam Khan, Mehnaz Kamal, Manal Mutlaq Alshammari, Raghad Mohammad Alharbi, Nuha Abdullah Althomali, Ibrahim Mohammed Alzimam, Abdullah Ayed Alshammari, Bashair Hamed Alharbi, Amer Mohammad Alshengeti, Abdulmonem A Alsaleh, Shayea A Alqahtani, Ali A Rabaan
MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature. Biomedicines 10 (11) (2022)